Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer.
Yongyi WuHaoxiang LiYuling YanKai WangYongna ChengYangyang LiXinyuan ZhuJin XieXilin Sun
Published in: International journal of nanomedicine (2020)
Gd@C-dots-Cys-ZEGFR:1907 is a high-affinity EGFR-targeting probe with efficient renal clearance and is therefore a promising contrast agent for clinical applications such as diagnosis and treatment of NSCLC EGFR-positive malignant tumors.